CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 1 filers reported holding CASTLE BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151 | +15.3% | 8,982 | -5.6% | 0.00% | – |
| Q2 2023 | $131 | -53.5% | 9,510 | -23.6% | 0.00% | – |
| Q1 2023 | $282 | +81.9% | 12,454 | +89.0% | 0.00% | – |
| Q4 2022 | $155 | -100.0% | 6,588 | -73.9% | 0.00% | -100.0% |
| Q3 2022 | $658,000 | +2430.8% | 25,234 | +2013.4% | 0.00% | – |
| Q2 2022 | $26,000 | -83.6% | 1,194 | -66.4% | 0.00% | – |
| Q1 2022 | $159,000 | – | 3,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |